Venlafaxine Hydrochloride extended release capsules, 37.5 mg, 30-count bottles, Rx Only, Manufact...

FDA Recall #D-0474-2017 — Class II — December 22, 2016

Recall #D-0474-2017 Date: December 22, 2016 Classification: Class II Status: Terminated

Product Description

Venlafaxine Hydrochloride extended release capsules, 37.5 mg, 30-count bottles, Rx Only, Manufactured for: Aurobindo Pharma USA, Inc. 2400 Route 130 North, Dayton, NJ 08810 Manufactured by: Aurobindo Pharma Limited Hyderabad-500 072 India, NDC 65862-527-30

Reason for Recall

Failed Tablet/Capsule Specifications: Some bottles contain punctured, and/or clumped/melted capsules.

Recalling Firm

Aurobindo Pharma USA Inc — Plainsboro, NJ

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

47,040 bottles

Distribution

Nationwide in the US

Code Information

Lot #: VI3716010-A, Exp. 04/2018

Status

Terminated

Voluntary / Mandated

Voluntary: Firm initiated